Notes
In the UK the MHRA has accepted reports from patients since 2004. In the Netherlands, Denmark and in the USA this happened earlier, but little is known about how the agencies have used these reports.
For a more in-depth discussion, see the 11 Oct 2003 issue of the British Medical Journal, vol. 327, no. 7419.
References
Talalay P (ed) (1964) Drugs in our society. Johns Hopkins Press, Baltimore
Proger S (ed) (1968) The medicated society. Collier-Macmillan, Toronto
Bush P, Trakas D, Sanz E et al (eds) (1996) Children, medicines and culture. Haworth, Binghampton, NY
Trakas D, Sanz E (eds) (1996) Childhood and medicine use in cross-cultural perspective: a European concerted action. DG XII Euro-Report EUR 16646EN. European Commission, Luxembourg
Sanz E (1999) Pharmacological treatment for asthma: disease, diagnosis, drugs and patients. Int J Risk Saf Med 12:157–162
NHSS (2004) National healthyschool standarddrug education (including alcohol and tobacco). http://www.wiredforhealth.gov.uk/PDF/nhss_drug_education_2004.pdf. Accessed 7 Oct 2007
Medawar C, Herxheimer A, Bell A, Jofre S (2002) Paroxetine, PANORAMA and user reporting of ADRs: consumer intelligence matters in clinical practice and post-marketing drug surveillance. Int J Risk Saf Med 15(4):161–169
Medawar C, Herxheimer A (2003/2004) A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine. Int J Risk Saf Med 16:3–17
Golomb BA, McGraw JJ, Evans MA, Dimsdale JE (2007) Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance. Drug Saf 30:669–675
International Society of Drug Bulletins (2007) http://www.isdbweb.org. Accessed 7 Oct 2007
ISDB (2001) Declaration on therapeutic advance in the use of medicines. http://www.isdbweb/pag/documents/ISDB-decl-english.pdf. Accessed 14 Nov 2007
Chalmers I, Altman DG (eds) (1995) Systematic reviews. BMJ, London
Egger M, Davey Smith G, Altman DG (eds) (2001) Systematic reviews in health care: meta-analysis in context, 2nd edn. BMJ, London
The Cochrane Library (2007) http://thecochranelibrary.com. Accessed 7 Oct 2007
Loke YK, Price D, Herxheimer A (2007) For the Cochrane adverse effects methods group. Systematic reviews of adverse effects: framework for a structured approach. BMC Med Res Methodol 7:32
Waller PC, Wood SM, Langman MJS, Breckenridge AM, Rawlins MD (1992) Review of company postmarketing surveillance studies. BMJ 304:14142–14770
Nieto A, Mazon A, Pamies R et al (2007) Adverse effects of inhaled corticosteroids in funded and nonfunded studies. Arch Intern Med 167:2047–2053
Health Technology Assessment (2007) NIHR Health Technology Assessment Programme. http://www.hta.nhsweb.nhs.uk/. Accessed 11 Nov 2007
National Institute for Health and Clinical Excellence (2007) http://www.nice.org.uk. Accessed 10 Nov 2007
INAHTA (2007) http://www.inahta.org. Accessed 10 Nov 2007
Guidelines International Network (2007) http://www.g-i-n.net. Accessed 11 Nov 2007
Mayor S (2006) Severe adverse reactions prompt call for trial design changes. BMJ 332:683
Rosenthal E (2006) Ill-fated U.K. drug trial bares testing loopholes. Herald Tribune, New York. http://www.iht.com/articles/2006/07/30/news/pharma.php. Accessed 10 Nov 2007
Laurence DR (2006) Research ethics committees and the law: indemnity and independence. Res Ethics Rev 2:140–143
Meador CK (1994) The last well person. N Engl J Med 330(6):440–441
Herxheimer A, Ziebland S (2004) The DIPEx project: collecting personal experiences of illness and health care. In: Hurwitz B, Greenhalgh T, Skultans V (eds) Narrative research in health and illness. BMJ Books, Blackwell
Shirkey HJ (1968) Pediatrics. 72(1):119–120
Bohaychuck W, Ball G (2004) Conducting GCP complaint clinical research. Some of their findings are summarised in: Medawar C, Hardon A (eds) Medicines out of control? Aksant, Amsterdam, pp 166–169
Illich I (1975) Medical nemesis: the expropriation of health. Marion Boyars, London
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Herxheimer, A., Sanz, E. Social, cultural and ethical aspects of drug use—changes over 40 years: a personal look back. Eur J Clin Pharmacol 64, 107–114 (2008). https://doi.org/10.1007/s00228-007-0429-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-007-0429-7